Roy E. Strowd, MEd III, MD

About Me

Education: MD, Wake Forest School of Medicine, 2009
Residency: Neurology, North Carolina Baptist Hospital, 2013
Fellowship: Neurology, Johns Hopkins Hospital, 2015
Board Certifications: American Board of Psychiatry and Neurology, Neurology
Positions: Assistant Professor, Neurology; Assistant Professor, Hematology and Oncology
Departments and Affiliations: Neurology; Hematology and Oncology; Center for Precision Medicine

Resident & Fellow Rounds. Millichap JJ, Strowd RE. Neurology. 2019 Feb; 92(9):440-442.
Trial of intrathecal rituximab in progressive multiple sclerosis patients with evidence of leptomeningeal contrast enhancement. Bhargava P, Wicken C, Smith MD, Strowd RE, Cortese I, Reich DS, Calabresi PA, Mowry EM. Mult Scler Relat Disord. 2019 May; 30:136-140.
Conversation Starter: Advancing the Theory of Peer-Assisted Learning. Callese T, Strowd R, Navarro B, Rosenberg I, Waasdorp Hurtado C, Tai J, Riddle JM, Cianciolo AT. Teach Learn Med. ; 31(1):7-16.
Resident & Fellow Rounds. Millichap JJ, Strowd RE. Neurology. 2018 Nov; 91(22):1022-1024.
Safety of pioglitazone during and after radiation therapy in patients with brain tumors: a phase I clinical trial. Cramer CK, Alphonse-Sullivan N, Isom S, Metheny-Barlow LJ, Cummings TL, Page BR, Brown DR, Blackstock AW, Peiffer AM, Strowd RE, Rapp S, Lesser GJ, Shaw EG, Chan MD. J. Cancer Res. Clin. Oncol. 2019 Feb; 145(2):337-344.

View More Publications